首页> 外文期刊>Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions >Emergency valve‐in‐valve transcatheter aortic valve replacement in a patient with degenerated bioprosthetic aortic stenosis and cardiogenic shock on veno‐arterial extracorporeal membrane oxygenation
【24h】

Emergency valve‐in‐valve transcatheter aortic valve replacement in a patient with degenerated bioprosthetic aortic stenosis and cardiogenic shock on veno‐arterial extracorporeal membrane oxygenation

机译:应急阀内经触控管主动脉瓣在患者中更换,具有退化的生物假性主动脉狭窄和静脉动脉体外膜氧合的血管生成休克

获取原文
获取原文并翻译 | 示例
           

摘要

The use of transcatheter aortic valve replacement (TAVR) as an acute treatment in severe decompensated bioprosthetic aortic valve disease is not well documented. We describe herein a unique case in which valve‐in‐valve (ViV) TAVR was successfully used as both an emergency salvage therapy and a bridge to definitive fourth reoperative aortic valve replacement (AVR) in a young patient with cardiogenic shock secondary to bioprosthetic aortic valve stenosis who was dependent on veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO). ? 2017 Wiley Periodicals, Inc.
机译:经沟管主动脉瓣置换(TAVR)作为严重失代偿的生物假体主动脉瓣病的急性治疗没有充分记录。 我们在此描述了一种独特的情况,其中阀门内(VIV)TAVR成功地用作紧急救助治疗和桥梁,以至于患有生物原始主动脉的心形成休克的年轻患者中的年轻患者中的最终第四个功能性主动脉瓣替代(AVR) 依赖于静脉动脉体外膜氧合(Va-Ecmo)的阀门狭窄。 还 2017年Wiley期刊,Inc。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号